Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy

by Marcelin, AG, Charpentier, C, Wirden, M, Descamps, D, Calvez, V
Published 2010

Prevalence of resistance and HIV-1 protease mutation patterns after failures with fosamprenavir-containing regimens

by Marcelin, AG, Charpentier, C, Ferreira, C, Wirden, M, Lemarchand, C, Descamps, D, Calvez, V
Published 2010

Upgraded Cobas Ampliprep-Cobas TaqMan Version 2.0 HIV-1 RNA Quantification Assay versus First Version: Correction of Underestimations

by Wirden, M., Tubiana, R., Fourati, S., Thevenin, M., Simon, A., Canestri, A., Ait-Arkoub, Z., Soulie, C., Marcelin, A. G., Katlama, C., Calvez, V.
Published 2011

Impact of Discrepancies between the Abbott RealTime and Cobas TaqMan Assays for Quantification of Human Immunodeficiency Virus Type 1 Group M Non-B Subtypes

by Wirden, M., Tubiana, R., Marguet, F., Leroy, I., Simon, A., Bonmarchand, M., Ait-Arkoub, Z., Murphy, R., Marcelin, A. G., Katlama, C., Calvez, V.
Published 2009